Abstract:BACKGROUND:Glioblastoma stem-like cells (GSCs) are hypothesized to contribute to self-renewal and therapeutic resistance in glioblastoma multiforme (GBM) tumors. Constituting only a small percentage of cancer cells, GSCs possess "stem-like", tumor-initiating properties and display resistance to irradiation and chemotherapy. Thus, novel approaches that can be used to suppress GSCs are urgently needed. A new carbon material-graphene oxide (GO), has been reported to show potential for use in tumor therapy. However, the exact effect of GO on GSCs and the inherent mechanism underlying its action are not clear. In this study, we aimed to investigate the usefulness of GO to inhibit the growth and promote the differentiation of GSCs, so as to suppress the malignancy of GBM.METHODS:In vitro effects of GO on sphere-forming ability, cell proliferation and differentiation were evaluated in U87, U251 GSCs and primary GSCs. The changes in cell cycle and the level of epigenetic modification H3K27me3 were examined. GO was also tested in vivo against U87 GSCs in mouse subcutaneous xenograft models by evaluating tumor growth and histological features.RESULTS:We cultured GSCs to explore the effect of GO and the underlying mechanism of its action. We found, for the first time, that GO triggers the inhibition of cell proliferation and induces apoptotic cell death in GSCs. Moreover, GO could promote the differentiation of GSCs by decreasing the expression of stem cell markers (SOX2 and CD133) and increasing the expression of differentiation-related markers (GFAP and β-III tubulin). Mechanistically, we found that GO had a striking effect on GSCs by inducing cell cycle arrest and epigenetic regulation. GO decreased H3K27me3 levels, which are regulated by EZH2 and associated with transcriptional silencing, in the promoters of the differentiation-related genes GFAP and β-III tubulin, thereby enhancing GSC differentiation. In addition, compared with untreated GSCs, GO-treated GSCs that were injected into nude mice exhibited decreased tumor growth in vivo.CONCLUSION:These results suggested that GO could promote differentiation and reduce malignancy in GSCs via an unanticipated epigenetic mechanism, which further demonstrated that GO is a potent anti-GBM agent that could be useful for future clinical applications.

In Vitro Enhancement of Dendritic Cell-Mediated Anti-Glioma Immune Response by Graphene Oxide

Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas

Graphene Oxide Suppresses the Growth and Malignancy of Glioblastoma Stem Cell-Like Spheroids Via Epigenetic Mechanisms

A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy

Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model

Poria cocos polysaccharide-functionalized graphene oxide nanosheet induces efficient cancer immunotherapy in mice

Abstract LB334: Assessment of the potential of graphene oxide as an antigen delivery platform for cancer immunotherapy

Immunotherapy of Intracranial G422 Glioblastoma with Dendritic Cells Pulsed with Tumor Extract or RNA

Functionalized Graphene Oxide Against U251 Glioma Cells and Its Molecular Mechanism.

The Immunotoxicity of Graphene Oxides and the Effect of Pvp-Coating

Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma

Transferrin Modified Graphene Oxide For Glioma-Targeted Drug Delivery: In Vitro And In Vivo Evaluations

Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents.

Immunostimulatory Oligonucleotides-Loaded Cationic Graphene Oxide with Photothermally Enhanced Immunogenicity for Photothermal/immune Cancer Therapy

Biofunctionalized graphene oxide nanosheet for amplifying antitumor therapy: Multimodal high drug encapsulation, prolonged hyperthermal window, and deep-site burst drug release

A novel plasma membrane-phillic graphene oxide nanocarrier for neuropeptide delivery to generate tolerogenic dendritic cells in GVHD Immunotherapy

Immunomodulatory properties of graphene oxide for osteogenesis and angiogenesis

Graphene oxide-based plasma membrane-philic delivery platform to generate tolerogenic dendritic cells in GVHD immunotherapy

Cytotoxicity Effect of Graphene Oxide on Human MDA-MB-231 Cells

Application of graphene oxide in tumor targeting and tumor therapy

Regulation of astrocyte activity and immune response on graphene oxide-coated titanium by electrophoretic deposition